Centessa Pharmaceuticals plc (CNTA) Misses Q2 EPS by 5c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.38), $0.05 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
• NetApp (NTAP) Tops Q1 EPS by 47c, Beats on Revenue